[Anti-endotoxin therapy in liver diseases].
D000538:Aluminum Silicates / Q000627:therapeutic use; D000617:Aminoglycosides / Q000627:therapeutic use*; D000818:Animals; D001241:Aspirin / Q000627:therapeutic use; D001729:Bismuth / Q000627:therapeutic use; D002462:Cell Membrane / Q000378:metabolism; D002648:Child; D006224:Cricetinae; D004035:Diet Therapy; D004731:Endotoxins / Q000037:antagonists & inhibitors* / Q000276:immunology; D004926:Escherichia coli; D005688:Galactosamine / Q000378:metabolism; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D007408:Intestinal Absorption / Q000187:drug effects; D007792:Lactulose / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D008033:Limulus Test; D008099:Liver / Q000503:physiopathology; D008107:Liver Diseases / Q000628:therapy*; D008274:Magnesium / Q000627:therapeutic use; D017616:Magnesium Compounds; D009942:Organometallic Compounds; D011112:Polymyxin B / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D012459:Salicylates / Q000627:therapeutic use; D012825:Silicon / Q000627:therapeutic use; D017655:Silicon Compounds; D013654:Taurine / Q000031:analogs & derivatives*; D013829:Thiadiazines / Q000627:therapeutic use; D014734:Vibrio cholerae
D000538:Aluminum Silicates; D000617:Aminoglycosides; D004731:Endotoxins; D017616:Magnesium Compounds; D009942:Organometallic Compounds; D012459:Salicylates; D017655:Silicon Compounds; D013829:Thiadiazines; D013654:Taurine; D007978:Levamisole; D007792:Lactulose; C015715:bismuth subsalicylate; D005688:Galactosamine; C012566:taurolidine; D011433:Propranolol; D008274:Magnesium; D011112:Polymyxin B; D001241:Aspirin; D001729:Bismuth; C026325:attapulgite; D007213:Indomethacin; D012825:Silicon
La terapia anti-endotossinica nelle epatopatie.